Literature DB >> 26826074

Ethics and Regulatory Challenges and Opportunities in Patient-Centered Comparative Effectiveness Research.

Jeremy Sugarman1.   

Abstract

The Affordable Care Act includes provisions for the conduct of large-scale, patient-centered comparative effectiveness research. Such efforts aim toward the laudable moral goal of having evidence to improve health care decision making. Nevertheless, these pragmatic clinical research efforts that typically pose minimal incremental risk and are enmeshed in routine care settings perhaps surprisingly encounter an array of ethics and regulatory challenges and opportunities for academic health centers. An emphasis on patient-centeredness forces an examination of the appropriateness of traditional methods used to protect the rights, interests, and welfare of participants. At the same time, meaningful collaboration with patients throughout the research process also necessitates ensuring that novel approaches to research (including recruitment and consent) entail necessary protections regarding such issues as privacy. As the scientific and logistical aspects of this research are being developed, substantial attention is being focused on the accompanying ethics and regulatory issues that have emerged, which should help to facilitate ethically appropriate research in a variety of contexts.

Entities:  

Mesh:

Year:  2016        PMID: 26826074      PMCID: PMC4811702          DOI: 10.1097/ACM.0000000000001096

Source DB:  PubMed          Journal:  Acad Med        ISSN: 1040-2446            Impact factor:   6.893


  8 in total

1.  How a unique provision in the American Recovery and Reinvestment Act set a foundation for the Patient-Centered Outcomes Research Institute.

Authors:  Joe Selby; Jean Slutsky
Journal:  J Comp Eff Res       Date:  2014-11       Impact factor: 1.744

2.  Ethics, regulation, and comparative effectiveness research: time for a change.

Authors:  Richard Platt; Nancy E Kass; Deven McGraw
Journal:  JAMA       Date:  2014-04-16       Impact factor: 56.272

3.  Ethics and regulatory complexities for pragmatic clinical trials.

Authors:  Jeremy Sugarman; Robert M Califf
Journal:  JAMA       Date:  2014-06-18       Impact factor: 56.272

4.  Medical research: US patient network safeguards data.

Authors:  Joe V Selby
Journal:  Nature       Date:  2014-05-29       Impact factor: 49.962

5.  Exploring the ethical and regulatory issues in pragmatic clinical trials.

Authors:  Robert M Califf; Jeremy Sugarman
Journal:  Clin Trials       Date:  2015-09-15       Impact factor: 2.486

6.  Anticipated Ethics and Regulatory Challenges in PCORnet: The National Patient-Centered Clinical Research Network.

Authors:  Joseph Ali; Robert Califf; Jeremy Sugarman
Journal:  Account Res       Date:  2016       Impact factor: 2.622

7.  Ethical and regulatory issues of pragmatic cluster randomized trials in contemporary health systems.

Authors:  Monique L Anderson; Robert M Califf; Jeremy Sugarman
Journal:  Clin Trials       Date:  2015-03-01       Impact factor: 2.486

8.  Launching PCORnet, a national patient-centered clinical research network.

Authors:  Rachael L Fleurence; Lesley H Curtis; Robert M Califf; Richard Platt; Joe V Selby; Jeffrey S Brown
Journal:  J Am Med Inform Assoc       Date:  2014-05-12       Impact factor: 4.497

  8 in total
  4 in total

1.  Improving informed consent: Stakeholder views.

Authors:  Emily E Anderson; Susan B Newman; Alicia K Matthews
Journal:  AJOB Empir Bioeth       Date:  2017-08-02

2.  Ethics and Science in the Participatory Era: A Vignette-Based Delphi Study.

Authors:  Elizabeth Bromley; Lisa Mikesell; Dmitry Khodyakov
Journal:  J Empir Res Hum Res Ethics       Date:  2017-07-10       Impact factor: 1.742

3.  IRB Oversight of Patient-Centered Outcomes Research: A National Survey of IRB Chairpersons.

Authors:  Joel S Weissman; Eric G Campbell; I Glenn Cohen; Holly Fernandez Lynch; Emily A Largent; Avni Gupta; Ronen Rozenblum; Melissa Abraham; Karen Spikes; Maureen Fagan; Martie Carnie
Journal:  J Empir Res Hum Res Ethics       Date:  2018-06-14       Impact factor: 1.742

4.  Hospital recruitment for a pragmatic cluster-randomized clinical trial: Lessons learned from the COMPASS study.

Authors:  Anna M Johnson; Sara B Jones; Pamela W Duncan; Cheryl D Bushnell; Sylvia W Coleman; Laurie H Mettam; Anna M Kucharska-Newton; Mysha E Sissine; Wayne D Rosamond
Journal:  Trials       Date:  2018-01-26       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.